The 19 analysts offering 12-month price forecasts for Karuna Therapeutics Inc have a median target of 285.00, with a high estimate of 330.00 and a low estimate of 209.00. The median estimate represents a +48.25% increase from the last price of 192.24.
The current consensus among 20 polled investment analysts is to Buy stock in Karuna Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$2.24
Reporting Date Feb 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.